All articles by Luke Christou

Luke Christou is a B2B and technology journalist and contributor across the Verdict network.

Celgene partners with AI drug discovery startup to make drug trials shorter

Biotechnology company Celgene has partnered with Exscientia, an artificial intelligence startup aiming to reduce the time it takes to bring…
How to prevent contamination in a biopharmaceutical manufacturing operation

Unlike traditional pharmaceuticals, biopharmaceuticals are a result of the genetic manipulation of living cells. Developing these extremely complex structures comes…
Should pharmaceutical manufacturers invest in single-use containment?

In an industry where safety is of the utmost importance ILC Dover’s single-use systems offer some of the most advanced…
Flexible powder containment: ILC Dover’s DoverPac system

DoverPac is a flexible containment system developed by engineering development and manufacturing company ILC Dover in collaboration with global pharmaceutical…
Effective containment systems for high potency active pharmaceutical ingredients (HP APIs)

The rules and regulations that pharmaceutical manufacturers must follow largely vary between regulatory agencies. However, there is one thing that…

How CMOs can benefit from single-use solutions

Pharmaceutical companies are increasingly turning to contract manufacturing organisations (CMOs) to make their products, which frees up more time and…
The high cost of contamination in drugs manufacturing

Pharmaceuticals is one of the highest value industries globally, with 28 of the 1,000 largest companies in the world by…
How safe is your process? The usual causes of pharmaceutical contamination

Large-scale plant shutdowns are somewhat rare in the pharmaceutical industry, given the high level of care that manufacturers must take…
ILC Dover flexible isolators: A cost-effective way to maximise containment

High potency active pharmaceutical ingredients (HP APIs) are the fastest growing segment of the API market. This is mainly due…